Robert J. Holt

497 total citations
46 papers, 358 citations indexed

About

Robert J. Holt is a scholar working on Rheumatology, Surgery and Pharmacology. According to data from OpenAlex, Robert J. Holt has authored 46 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 9 papers in Surgery and 9 papers in Pharmacology. Recurrent topics in Robert J. Holt's work include Inflammatory mediators and NSAID effects (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Robert J. Holt is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Robert J. Holt collaborates with scholars based in United States, Germany and United Kingdom. Robert J. Holt's co-authors include Jeffrey D. Kent, Alfonso E. Bello, Amy Grahn, Patricia Rice, Rieke Alten, Megan Francis‐Sedlak, Frank Buttgereit, Brian LaMoreaux, Peter Strike and Kenneth D. Bruce and has published in prestigious journals such as Journal of Clinical Oncology, Ophthalmology and Annals of the Rheumatic Diseases.

In The Last Decade

Robert J. Holt

42 papers receiving 326 citations

Peers

Robert J. Holt
Christopher J. Needs Australia
Shigeru Yamada Japan
Howard Klausner United States
Hamid Noshad Iran
Farbod Raiszadeh United States
Claudia B. Karwoski United States
Barry C. Herzlich United States
Vinícius Daher Alvares Delfino Brazil
Isidor Minović Netherlands
Neila Fathallah Tunisia
Christopher J. Needs Australia
Robert J. Holt
Citations per year, relative to Robert J. Holt Robert J. Holt (= 1×) peers Christopher J. Needs

Countries citing papers authored by Robert J. Holt

Since Specialization
Citations

This map shows the geographic impact of Robert J. Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Holt more than expected).

Fields of papers citing papers by Robert J. Holt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Holt. The network helps show where Robert J. Holt may publish in the future.

Co-authorship network of co-authors of Robert J. Holt

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Holt. A scholar is included among the top collaborators of Robert J. Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Holt. Robert J. Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kahaly, George J., et al.. (2025). Teprotumumab Improves Quality of Life in Thyroid Eye Disease: Meta-analysis and Matching-adjusted Indirect Comparison. Journal of the Endocrine Society. 9(6). bvaf063–bvaf063. 2 indexed citations
2.
Morlock, Robert, Deepan Dalal, Victoria Divino, et al.. (2024). Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis. Rheumatology and Therapy. 12(1). 37–51.
3.
Smith, Terry J., Kate Hsu, Sun H. Kim, et al.. (2024). Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials. Ophthalmology. 131(7). 815–826. 7 indexed citations
4.
Francis‐Sedlak, Megan, Brian LaMoreaux, Lissa Padnick‐Silver, Robert J. Holt, & Alfonso E. Bello. (2020). Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study. Rheumatology and Therapy. 8(1). 183–197. 16 indexed citations
5.
Díaz, George A., Andreas Schulze, Nicola Longo, et al.. (2019). Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients. Molecular Genetics and Metabolism. 127(4). 336–345. 10 indexed citations
6.
Clayman, Gary L., Ian D. Hay, Mimi I. Hu, et al.. (2018). 88 th Annual Meeting of the American Thyroid Association. Thyroid. 28(S1). P–1. 6 indexed citations
7.
Berry, Susan A., Jerry Vockley, Alexander A. Vinks, et al.. (2018). Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disorders. Molecular Genetics and Metabolism. 125(3). 251–257. 8 indexed citations
8.
Williams, Joanna M., Farjana Fattah, Ryan Smith, et al.. (2018). P2.01-37 A Ph 1/2 Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) with Docetaxel in pts with Previously Treated NSCLC. Journal of Thoracic Oncology. 13(10). S679–S679. 1 indexed citations
9.
Lovell, Daniel J., Jason Dare, Megan Francis‐Sedlak, et al.. (2018). A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis. Pediatric Rheumatology. 16(1). 41–41. 6 indexed citations
10.
Dikranian, Ara, et al.. (2017). Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study. Rheumatology and Therapy. 4(2). 363–374. 1 indexed citations
11.
Halls, Serena, Sarah Hewlett, Sarah Mackie, et al.. (2016). Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group. The Journal of Rheumatology. 44(12). 1904–1910. 13 indexed citations
12.
Alten, Rieke, Robert J. Holt, Amy Grahn, et al.. (2015). Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone. Scandinavian Journal of Rheumatology. 44(5). 354–358. 13 indexed citations
13.
Kent, Jeffrey D., et al.. (2015). Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study. Current Medical Research and Opinion. 32(2). 241–250. 28 indexed citations
14.
Holt, Robert J., John G. Fort, Amy Grahn, Jeffrey D. Kent, & Alfonso E. Bello. (2015). Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib. The Physician and Sportsmedicine. 43(3). 200–212. 12 indexed citations
15.
Holt, Robert J., et al.. (2015). Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers. Postgraduate Medicine. 127(6). 581–590. 12 indexed citations
16.
Bello, Alfonso E. & Robert J. Holt. (2014). Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications. Drug Safety. 37(11). 897–902. 30 indexed citations
17.
18.
19.
Holt, Robert J., Peter Strike, & Kenneth D. Bruce. (1996). Phylogenetic analysis oftnpR. genes in mercury resistant soil bacteria: the relationship between DNA sequencing and RFLP typing approaches. FEMS Microbiology Letters. 144(1). 95–102. 6 indexed citations
20.
Holt, Robert J., et al.. (1981). Hyperglycemia associated with Propranolol and Chlorpropamide Coadministration. Drug Intelligence & Clinical Pharmacy. 15(7-8). 599–600. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Needs Breakdown of academic impact, for papers by Shigeru Yamada Breakdown of academic impact, for papers by Howard Klausner Breakdown of academic impact, for papers by Hamid Noshad Breakdown of academic impact, for papers by Farbod Raiszadeh Breakdown of academic impact, for papers by Claudia B. Karwoski Breakdown of academic impact, for papers by Barry C. Herzlich Breakdown of academic impact, for papers by Vinícius Daher Alvares Delfino Breakdown of academic impact, for papers by Isidor Minović Breakdown of academic impact, for papers by Neila Fathallah
Rankless by CCL
2026